메뉴 건너뛰기




Volumn 55, Issue 5, 2014, Pages 1038-1048

The significance of combining radiotherapy with chemotherapy for early stage extranodal natural killer/T-cell lymphoma, nasal type: A systematic review and meta-analysis

Author keywords

Chemotherapy; Extranodal natural killer T cell lymphoma; Meta analysis; Nasal type; Radiotherapy; Systematic review

Indexed keywords

ANTINEOPLASTIC AGENT;

EID: 84899723410     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2013.827789     Document Type: Article
Times cited : (22)

References (79)
  • 1
    • 0028064764 scopus 로고
    • A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group
    • Harris NL, Jaff e ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392.
    • (1994) Blood , vol.84 , pp. 1361-1392
    • Harris, N.L.1    Jaffe, E.S.2    Stein, H.3
  • 2
    • 0033395790 scopus 로고    scopus 로고
    • The world health organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues report of the clinical advisory committee meeting, airlie house, virginia, november, 1997
    • Harris NL, Jaff e ES, Diebold J, et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol 1999; 10: 1419-1432.
    • (1999) Ann Oncol , vol.10 , pp. 1419-1432
    • Harris, N.L.1    Jaffe, E.S.2    Diebold, J.3
  • 3
    • 61349149366 scopus 로고    scopus 로고
    • Swerdlow SH Campo E Harris NK et al editors. World Health Organization classification of tumours of haematopoietic and lymphoid tissues, Lyon: IARC Press
    • Chan J KC, Quintanilla-Martinez L, Ferry J A. E xtranodal NK/ T-cell lymphoma, nasal type. In: Swerdlow SH, Campo E, Harris NK, et al, editors. World Health Organization classification of tumours of haematopoietic and lymphoid tissues, Lyon: IARC Press; 2008. pp 285-288.
    • (2008) Extranodal NK/ T-cell lymphoma nasal type , pp. 285-288
    • Chan, J.K.C.1    Quintanilla-Martinez, L.2    Ferry, J.A.3
  • 4
    • 67649389564 scopus 로고    scopus 로고
    • Extranodal nasal type NK/Tcell lymphoma: Clinicopathologic and prognostic study of 55 cases
    • Li L, Liu YH, Zhuang HG, et al. Extranodal nasal type NK/Tcell lymphoma: Clinicopathologic and prognostic study of 55 cases. Zhonghua Bing Li Xue Za Zhi 2009; 38: 237-242.
    • (2009) Zhonghua Bing Li Xue Za Zhi , vol.38 , pp. 237-242
    • Li, L.1    Liu, Y.H.2    Zhuang, H.G.3
  • 5
    • 33846924599 scopus 로고    scopus 로고
    • Primary nasal natural killer/T-cell lymphomas: Classification and clinicopathological features
    • Sandner A, Kosling S, Helmbold P, et al. Primary nasal natural killer/T-cell lymphomas: Classification and clinicopathological features. HNO 2007; 55: 93-99.
    • (2007) HNO , vol.55 , pp. 93-99
    • Sandner, A.1    Kosling, S.2    Helmbold, P.3
  • 6
    • 84871614389 scopus 로고    scopus 로고
    • Extranodal nk/t-cell lymphoma, nasal type: A report of 73 cases at md anderson cancer center
    • Li S, Feng X, Li T, et al. Extranodal NK/T-cell lymphoma, nasal type: A report of 73 cases at MD Anderson Cancer Center. Am J Surg Pathol 2013; 37: 14-23.
    • (2013) Am J Surg Pathol , vol.37 , pp. 14-23
    • Li, S.1    Feng, X.2    Li, T.3
  • 7
    • 84860634137 scopus 로고    scopus 로고
    • Extranodal NK/T-cell lymphoma, nasal type (angiocentric T-cell lymphoma): A review about the terminology
    • Metgud RS, Doshi J J, Gaurkhede S, et al. Extranodal NK/T-cell lymphoma, nasal type (angiocentric T-cell lymphoma): A review about the terminology. J Oral Maxillofac Pathol 2011; 15: 96-100.
    • (2011) J Oral Maxillofac Pathol , vol.15 , pp. 96-100
    • Metgud, R.S.1    Doshi, J.J.2    Gaurkhede, S.3
  • 8
    • 43449124461 scopus 로고    scopus 로고
    • The spectrum of epstein-barr virus-Associated lymphoproliferative disease in korea: Incidence of disease entities by age groups
    • Cho EY, Kim KH, Kim WS, et al. The spectrum of Epstein-Barr virus-Associated lymphoproliferative disease in Korea: Incidence of disease entities by age groups. J Korean Med Sci 2008; 23: 185-192.
    • (2008) J Korean Med Sci , vol.23 , pp. 185-192
    • Cho, E.Y.1    Kim, K.H.2    Kim, W.S.3
  • 9
    • 84875920177 scopus 로고    scopus 로고
    • Immunomorphologic profile and Epstein-Barr virus status of a cohort of 35 cases of extranodal natural killer/T-cell lymphoma nasal type of upper aerodigestive tract from a tertiary care center in South India
    • Bugalia A, Manipadam MT, Nair S. Immunomorphologic profile and Epstein-Barr virus status of a cohort of 35 cases of extranodal natural killer/T-cell lymphoma, nasal type of upper aerodigestive tract from a tertiary care center in South India. Leuk Lymphoma 2012; 54: 1201-1207.
    • (2012) Leuk Lymphoma , vol.54 , pp. 1201-1207
    • Bugalia, A.1    Manipadam, M.T.2    Nair, S.3
  • 10
    • 65449159015 scopus 로고    scopus 로고
    • Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: A study of 136 cases from the International Peripheral T-Cell Lymphoma Project
    • Au WY, Weisenburger DD, Intragumtornchai T, et al. Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: A study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood 2009; 113: 3931-3937.
    • (2009) Blood , vol.113 , pp. 3931-3937
    • Au, W.Y.1    Weisenburger, D.D.2    Intragumtornchai, T.3
  • 11
    • 20444463408 scopus 로고    scopus 로고
    • Extranodal nasal type NK/T-cell lymphoma: Elucidating clinical prognostic factors for risk-based stratification of therapy
    • Lee J, Park YH, Kim WS, et al. Extranodal nasal type NK/T-cell lymphoma: Elucidating clinical prognostic factors for risk-based stratification of therapy. Eur J Cancer 2005; 41: 1402-1408.
    • (2005) Eur J Cancer , vol.41 , pp. 1402-1408
    • Lee, J.1    Park, Y.H.2    Kim, W.S.3
  • 12
    • 65349135347 scopus 로고    scopus 로고
    • Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphoma
    • Li Y X, Liu Q F, Fang H, et al. Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphoma. Clin Cancer Res 2009; 15: 2905-2912.
    • (2009) Clin Cancer Res , vol.15 , pp. 2905-2912
    • Li, Y.X.1    Liu, Q.F.2    Fang, H.3
  • 13
    • 0346724526 scopus 로고    scopus 로고
    • Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma
    • Li C C, Tien H F, Tang J L, et al. Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma. Cancer 2004; 100: 366-375.
    • (2004) Cancer , vol.100 , pp. 366-375
    • Li, C.C.1    Tien, H.F.2    Tang, J.L.3
  • 14
    • 51649091675 scopus 로고    scopus 로고
    • I nternational peripheral T-cell and natural killer/T-cell lymphoma study: Pathology fi ndings and clinical outcomes
    • Vose J, Armitage J, Weisenburger D. I nternational peripheral T-cell and natural killer/T-cell lymphoma study: Pathology fi ndings and clinical outcomes. J Clin Oncol 2008; 26: 4124-4130.
    • (2008) J Clin Oncol , vol.26 , pp. 4124-4130
    • Vose, J.1    Armitage, J.2    Weisenburger, D.3
  • 15
    • 57049170230 scopus 로고    scopus 로고
    • Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States
    • Abouyabis AN, Shenoy PJ, Lechowicz MJ, et al. Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States. Leuk Lymphoma 2008; 49: 2099-2107.
    • (2008) Leuk Lymphoma , vol.49 , pp. 2099-2107
    • Abouyabis, A.N.1    Shenoy, P.J.2    Lechowicz, M.J.3
  • 16
    • 0027394689 scopus 로고
    • Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma
    • Fisher R I, Gaynor E R, Dahlberg S, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 1993; 328: 1002-1006.
    • (1993) N Engl J Med , vol.328 , pp. 1002-1006
    • Fisher, R.I.1    Gaynor, E.R.2    Dahlberg, S.3
  • 17
    • 84872685986 scopus 로고    scopus 로고
    • Is there a role for consolidative radiotherapy in the treatment of aggressive and localized non-Hodgkin lymphoma? A systematic review with meta-Analysis
    • dos Santos LV, Lima JP, Lima CS, et al. Is there a role for consolidative radiotherapy in the treatment of aggressive and localized non-Hodgkin lymphoma? A systematic review with meta-Analysis. BMC Cancer 2012; 12: 288.
    • (2012) BMC Cancer , vol.12 , pp. 288
    • Dos Santos, L.V.1    Lima, J.P.2    Lima, C.S.3
  • 18
    • 67651159290 scopus 로고    scopus 로고
    • R-CHOP versus R-CVP in the treatment of follicular lymphoma: A meta-Analysis and critical appraisal of current literature
    • Siddhartha G, Vijay P. R-CHOP versus R-CVP in the treatment of follicular lymphoma: A meta-Analysis and critical appraisal of current literature. J Hematol Oncol 2009; 2: 14.
    • (2009) J Hematol Oncol , vol.2 , pp. 14
    • Siddhartha, G.1    Vijay, P.2
  • 19
    • 84864517049 scopus 로고    scopus 로고
    • Diffuse large B-cell lymphoma: Current strategies and future directions
    • Cultrera JL, Dalia SM. Diffuse large B-cell lymphoma: Current strategies and future directions. Cancer Control 2012; 19: 204-213.
    • (2012) Cancer Control , vol.19 , pp. 204-213
    • Cultrera, J.L.1    Dalia, S.M.2
  • 20
    • 4143102674 scopus 로고    scopus 로고
    • Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-hodgkin's lymphoma: Eastern cooperative oncology group study 1484
    • Horning SJ, Weller E, Kim K, et al. Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group study 1484. J Clin Oncol 2004; 22: 3032-3038.
    • (2004) J Clin Oncol , vol.22 , pp. 3032-3038
    • Horning, S.J.1    Weller, E.2    Kim, K.3
  • 21
    • 0036137935 scopus 로고    scopus 로고
    • Brief chemotherapy and involved-region irradiation for limited-stage diffuse large-cell lymphoma: An 18-year experience from the british columbia cancer agency
    • Shenkier TN, Voss N, Fairey R, et al. Brief chemotherapy and involved-region irradiation for limited-stage diffuse large-cell lymphoma: An 18-year experience from the British Columbia Cancer Agency. J Clin Oncol 2002; 20: 197-204.
    • (2002) J Clin Oncol , vol.20 , pp. 197-204
    • Shenkier, T.N.1    Voss, N.2    Fairey, R.3
  • 22
    • 0036720257 scopus 로고    scopus 로고
    • Early stage nasal NK/Tcell lymphoma: Clinical outcome, prognostic factors, and the effect of treatment modality
    • Cheung MM, Chan JK, Lau WH, et al. Early stage nasal NK/Tcell lymphoma: Clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys 2002; 54: 182-190.
    • (2002) Int J Radiat Oncol Biol Phys , vol.54 , pp. 182-190
    • Cheung, M.M.1    Chan, J.K.2    Lau, W.H.3
  • 23
    • 33747698361 scopus 로고    scopus 로고
    • Treatment outcome of front-line systemic chemotherapy for localized extranodal NK/T cell lymphoma in nasal and upper aerodigestive tract
    • Kim SJ, Kim BS, Choi CW, et al. Treatment outcome of front-line systemic chemotherapy for localized extranodal NK/T cell lymphoma in nasal and upper aerodigestive tract. Leuk Lymphoma 2006; 47: 1265-1273.
    • (2006) Leuk Lymphoma , vol.47 , pp. 1265-1273
    • Kim, S.J.1    Kim, B.S.2    Choi, C.W.3
  • 24
    • 79251541775 scopus 로고    scopus 로고
    • Unfavorable prognosis of elderly patients with early-stage extranodal nasal-Type NK/T-cell lymphoma
    • Wang Z Y, L i Y X, Wang H, et al. Unfavorable prognosis of elderly patients with early-stage extranodal nasal-Type NK/T-cell lymphoma. Ann Oncol 2011; 22: 390-396.
    • (2011) Ann Oncol , vol.22 , pp. 390-396
    • Wang, Z.Y.1    Li, Y.X.2    Wang, H.3
  • 25
    • 84872183512 scopus 로고    scopus 로고
    • Cyclophosphamide doxorubicin vincristine and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma nasal type: 13-year followup in 135 patients
    • Wang L, Xia ZJ, Huang HQ, et al. Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma, nasal type: 13-year followup in 135 patients. Int J Hematol 2012; 96: 617-623.
    • (2012) Int J Hematol , vol.96 , pp. 617-623
    • Wang, L.1    Xia, Z.J.2    Huang, H.Q.3
  • 26
    • 28444438522 scopus 로고    scopus 로고
    • Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/ II(E) extranodal NK/T-cell lymphoma, nasal type
    • Kim TM, Park YH, Lee SY, et al. Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/ II(E) extranodal NK/T-cell lymphoma, nasal type. Blood 2005; 106: 3785-3790.
    • (2005) Blood , vol.106 , pp. 3785-3790
    • Kim, T.M.1    Park, Y.H.2    Lee, S.Y.3
  • 27
    • 33644843494 scopus 로고    scopus 로고
    • Extranodal natural killer T-cell lymphoma, nasal-Type: A prognostic model from a retrospective multicenter study
    • Lee J, Suh C, Park Y H, et al. Extranodal natural killer T-cell lymphoma, nasal-Type: A prognostic model from a retrospective multicenter study. J Clin Oncol 2006; 24: 612-618.
    • (2006) J Clin Oncol , vol.24 , pp. 612-618
    • Lee, J.1    Suh, C.2    Park, Y.H.3
  • 28
    • 2342425819 scopus 로고    scopus 로고
    • Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: A single institute survey in Taiwan
    • You JY, Chi KH, Yang MH, et al. Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: A single institute survey in Taiwan. Ann Oncol 2004; 15: 618-625.
    • (2004) Ann Oncol , vol.15 , pp. 618-625
    • You, J.Y.1    Chi, K.H.2    Yang, M.H.3
  • 29
    • 37049003063 scopus 로고    scopus 로고
    • Early or up-front radiotherapy improved survival of localized extranodal NK/T-cell lymphoma, nasaltype in the upper aerodigestive tract
    • Huang MJ, Jiang Y, Liu WP, et al. Early or up-front radiotherapy improved survival of localized extranodal NK/T-cell lymphoma, nasaltype in the upper aerodigestive tract. Int J Radiat Oncol Biol Phys 2008; 70: 166-174.
    • (2008) Int J Radiat Oncol Biol Phys , vol.70 , pp. 166-174
    • Huang, M.J.1    Jiang, Y.2    Liu, W.P.3
  • 30
    • 18044390875 scopus 로고    scopus 로고
    • Nasal-Type NK/T cell lymphoma: Clinical features and treatment outcome
    • Lee J, Kim WS, Park YH, et al. Nasal-Type NK/T cell lymphoma: Clinical features and treatment outcome. Br J Cancer 2005; 92: 1226-1230.
    • (2005) Br J Cancer , vol.92 , pp. 1226-1230
    • Lee, J.1    Kim, W.S.2    Park, Y.H.3
  • 31
    • 0034906516 scopus 로고    scopus 로고
    • Early locoregional high-dose radiotherapy is associated with long-Term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx
    • Ribrag V, Ell Hajj M, Janot F, et al. Early locoregional high-dose radiotherapy is associated with long-Term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx. Leukemia 2001; 15: 1123-1126.
    • (2001) Leukemia , vol.15 , pp. 1123-1126
    • Ribrag, V.1    Ell Hajj, M.2    Janot, F.3
  • 32
    • 0032474694 scopus 로고    scopus 로고
    • Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate-And high-grade non-Hodgkin's lymphoma
    • Miller TP, Dahlberg S, Cassady JR, et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate-And high-grade non-Hodgkin's lymphoma. N Engl J Med 1998; 339: 21-26.
    • (1998) N Engl J Med , vol.339 , pp. 21-26
    • Miller, T.P.1    Dahlberg, S.2    Cassady, J.R.3
  • 33
    • 84858707231 scopus 로고    scopus 로고
    • Radiotherapy alone with curative intent in patients with stage I extranodal nasal-Type NK/T-cell lymphoma
    • Li YX, Wang H, Jin J, et al. Radiotherapy alone with curative intent in patients with stage I extranodal nasal-Type NK/T-cell lymphoma. Int J Radiat Oncol Biol Phys 2012; 82: 1809-1815.
    • (2012) Int J Radiat Oncol Biol Phys , vol.82 , pp. 1809-1815
    • Li, Y.X.1    Wang, H.2    Jin, J.3
  • 34
    • 31544434937 scopus 로고    scopus 로고
    • Extranodal natural killer/T-cell lymphoma, nasal type: The significance of radiotherapeutic parameters
    • Isobe K, Uno T, Tamaru J, et al. Extranodal natural killer/T-cell lymphoma, nasal type: The significance of radiotherapeutic parameters. Cancer 2006; 106: 609-615.
    • (2006) Cancer , vol.106 , pp. 609-615
    • Isobe, K.1    Uno, T.2    Tamaru, J.3
  • 35
    • 33644835980 scopus 로고    scopus 로고
    • Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma
    • Li YX, Yao B, Jin J, et al. Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma. J Clin Oncol 2006; 24: 181-189.
    • (2006) J Clin Oncol , vol.24 , pp. 181-189
    • Li, Y.X.1    Yao, B.2    Jin, J.3
  • 36
    • 0342905409 scopus 로고    scopus 로고
    • Angiocentric lymphoma of the head and neck: Patterns of systemic failure after radiation treatment
    • Kim GE, Cho JH, Yang WI, et al. Angiocentric lymphoma of the head and neck: Patterns of systemic failure after radiation treatment. J Clin Oncol 2000; 18: 54-63.
    • (2000) J Clin Oncol , vol.18 , pp. 54-63
    • Kim, G.E.1    Cho, J.H.2    Yang, W.I.3
  • 37
    • 80052036837 scopus 로고    scopus 로고
    • Failure patterns and clinical implications in early stage nasal natural killer/T-cell lymphoma treated with primary radiotherapy
    • Li YX, Liu QF, Wang WH, et al. Failure patterns and clinical implications in early stage nasal natural killer/T-cell lymphoma treated with primary radiotherapy. Cancer 2011; 117: 5203-5211.
    • (2011) Cancer , vol.117 , pp. 5203-5211
    • Li, Y.X.1    Liu, Q.F.2    Wang, W.H.3
  • 38
    • 37049021104 scopus 로고    scopus 로고
    • Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: Elucidating the significance of systemic chemotherapy
    • Guo Y, Lu JJ, Ma X, et al. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: Elucidating the significance of systemic chemotherapy. Oral Oncol 2008; 44: 23-30.
    • (2008) Oral Oncol , vol.44 , pp. 23-30
    • Guo, Y.1    Lu, J.J.2    Ma, X.3
  • 39
    • 84872087371 scopus 로고    scopus 로고
    • First-line combination of gemcitabine, oxaliplatin, and L-Asparaginase (GELOX) followed by involved-fi eld radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma
    • Wang L, Wang ZH, Chen XQ, et al. First-line combination of gemcitabine, oxaliplatin, and L-Asparaginase (GELOX) followed by involved-fi eld radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma. Cancer 2013; 119: 348-355.
    • (2013) Cancer , vol.119 , pp. 348-355
    • Wang, L.1    Wang, Z.H.2    Chen, X.Q.3
  • 40
    • 51249101520 scopus 로고    scopus 로고
    • A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type
    • Wu X, Li P, Zhao J, et al. A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type. Clin Oncol (R Coll Radiol) 2008; 20: 619-625.
    • (2008) Clin Oncol (R Coll Radiol) , vol.20 , pp. 619-625
    • Wu, X.1    Li, P.2    Zhao, J.3
  • 41
    • 34247899237 scopus 로고    scopus 로고
    • Combined chemotherapy and external beam radiation for stage IE and IIE natural killer T-cell lymphoma of nasal cavity
    • Wang B, L u J J, M a X, et al. Combined chemotherapy and external beam radiation for stage IE and IIE natural killer T-cell lymphoma of nasal cavity. Leuk Lymphoma 2007; 48: 396-402.
    • (2007) Leuk Lymphoma , vol.48 , pp. 396-402
    • Wang, B.1    Lu, J.J.2    Ma, X.3
  • 42
    • 0035074460 scopus 로고    scopus 로고
    • CHOP followed by involved fi eld radiation: Is it optimal for localized nasal natural killer/T-cell lymphoma
    • Kim WS, Song SY, Ahn YC, et al. CHOP followed by involved fi eld radiation: Is it optimal for localized nasal natural killer/T-cell lymphoma. Ann Oncol 2001; 12: 349-352.
    • (2001) Ann Oncol , vol.12 , pp. 349-352
    • Kim, W.S.1    Song, S.Y.2    Ahn, Y.C.3
  • 44
    • 34547450763 scopus 로고    scopus 로고
    • Practical methods for incorporating summary time-To-event data into meta-Analysis
    • Tierney JF, Stewart LA, Ghersi D, et al. Practical methods for incorporating summary time-To-event data into meta-Analysis. Trials 2007; 8: 16.
    • (2007) Trials , vol.8 , pp. 16
    • Tierney, J.F.1    Stewart, L.A.2    Ghersi, D.3
  • 45
    • 0030693603 scopus 로고    scopus 로고
    • Q uantitative synthesis in systematic reviews
    • Lau J, Ioannidis J P, Schmid C H. Q uantitative synthesis in systematic reviews. Ann Intern Med 1997; 127: 820-826.
    • (1997) Ann Intern Med , vol.127 , pp. 820-826
    • Lau, J.1    Ioannidis, J.P.2    Schmid, C.H.3
  • 46
    • 0028659004 scopus 로고
    • Operating characteristics of a rank correlation test for publication bias
    • Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
    • (1994) Biometrics , vol.50 , pp. 1088-1101
    • Begg, C.B.1    Mazumdar, M.2
  • 47
    • 84555203157 scopus 로고    scopus 로고
    • The clinical study of extranodal natural killer cell lymphoma, nasal type
    • Gui W, Zhao Z, Shen Q, et al. The clinical study of extranodal natural killer cell lymphoma, nasal type. Med Oncol 2011; 28 (Suppl. 1): S367-S372.
    • (2011) Med Oncol , vol.28 , Issue.SUPPL. 1
    • Gui, W.1    Zhao, Z.2    Shen, Q.3
  • 48
    • 84871958083 scopus 로고    scopus 로고
    • Therapy and prognosis analysis of 47 patients with extranodal NK/T-cell lymphoma
    • Zhang SS, Wei M, Li HH, et al. Therapy and prognosis analysis of 47 patients with extranodal NK/T-cell lymphoma. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2011; 19: 119-123.
    • (2011) Zhongguo Shi Yan Xue Ye Xue Za Zhi , vol.19 , pp. 119-123
    • Zhang, S.S.1    Wei, M.2    Li, H.H.3
  • 49
    • 34247578752 scopus 로고    scopus 로고
    • Extranodal NK/Tcell lymphoma, nasal type: Study of clinicopathologic and prognosis factors in a series of 78 cases from Peru
    • Barrionuevo C, Zaharia M, Martinez MT, et al. Extranodal NK/Tcell lymphoma, nasal type: Study of clinicopathologic and prognosis factors in a series of 78 cases from Peru. Appl Immunohistochem Mol Morphol 2007; 15: 38-44.
    • (2007) Appl Immunohistochem Mol Morphol , vol.15 , pp. 38-44
    • Barrionuevo, C.1    Zaharia, M.2    Martinez, M.T.3
  • 50
    • 84873998464 scopus 로고    scopus 로고
    • Retrospective analysis of treatment outcomes for extranodal NK/T-cell lymphoma (ENKL), nasal type, stage I-IIE: Single institute experience of combined modality treatment for early localized nasal extranodal NK/T-cell lymphoma (ENKL)
    • Lee J, Cho SG, Chung SM, et al. Retrospective analysis of treatment outcomes for extranodal NK/T-cell lymphoma (ENKL), nasal type, stage I-IIE: Single institute experience of combined modality treatment for early localized nasal extranodal NK/T-cell lymphoma (ENKL). Ann Hematol 2012; 92: 333-343.
    • (2012) Ann Hematol , vol.92 , pp. 333-343
    • Lee, J.1    Cho, S.G.2    Chung, S.M.3
  • 51
    • 36448976008 scopus 로고    scopus 로고
    • Prognostic factors and treatment outcome in early stage nasal NK/T cell lymphoma
    • Yao B, Li YX, Fang H, et al. Prognostic factors and treatment outcome in early stage nasal NK/T cell lymphoma. Zhonghua Xue Ye Xue Za Zhi 2006; 27: 222-225.
    • (2006) Zhonghua Xue Ye Xue Za Zhi , vol.27 , pp. 222-225
    • Yao, B.1    Li, Y.X.2    Fang, H.3
  • 52
    • 32844467983 scopus 로고    scopus 로고
    • Localized extranodal lymphoma of the head and neck: Retrospective analysis of a series of 107 patients from a single institution
    • Frata P, Buglione M, Grisanti S, et al. Localized extranodal lymphoma of the head and neck: Retrospective analysis of a series of 107 patients from a single institution. Tumori 2005; 91: 456-462.
    • (2005) Tumori , vol.91 , pp. 456-462
    • Frata, P.1    Buglione, M.2    Grisanti, S.3
  • 53
    • 0035196629 scopus 로고    scopus 로고
    • Non-hodgkin's malignant lymphoma of the sinonasal tract-Treatment outcome for 53 patients according to real classification
    • Hatta C, Ogasawara H, Okita J, et al. Non-Hodgkin's malignant lymphoma of the sinonasal tract-Treatment outcome for 53 patients according to REAL classification. Auris Nasus Larynx 2001; 28: 55-60.
    • (2001) Auris Nasus Larynx , vol.28 , pp. 55-60
    • Hatta, C.1    Ogasawara, H.2    Okita, J.3
  • 54
    • 0035194305 scopus 로고    scopus 로고
    • Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck
    • Kim GE, Lee SW, Chang SK, et al. Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck. Radiother Oncol 2001; 61: 261-269.
    • (2001) Radiother Oncol , vol.61 , pp. 261-269
    • Kim, G.E.1    Lee, S.W.2    Chang, S.K.3
  • 55
    • 14944369300 scopus 로고    scopus 로고
    • Treatment outcome of angiocentric T-cell and NK/T-cell lymphoma, nasal type: Radiotherapy versus chemoradiotherapy
    • Kim K, Chie EK, Kim CW, et al. Treatment outcome of angiocentric T-cell and NK/T-cell lymphoma, nasal type: Radiotherapy versus chemoradiotherapy. Jpn J Clin Oncol 2005; 35: 1-5.
    • (2005) Jpn J Clin Oncol , vol.35 , pp. 1-5
    • Kim, K.1    Chie, E.K.2    Kim, C.W.3
  • 56
    • 77956914232 scopus 로고    scopus 로고
    • Treatment outcome of radiotherapy alone versus radiochemotherapy in early stage nasal natural killer/ T-cell lymphoma
    • Ma H H, Qian L T, Pan H F, et al. Treatment outcome of radiotherapy alone versus radiochemotherapy in early stage nasal natural killer/ T-cell lymphoma. Med Oncol 2010; 27: 798-806.
    • (2010) Med Oncol , vol.27 , pp. 798-806
    • Ma, H.H.1    Qian, L.T.2    Pan, H.F.3
  • 57
    • 31444434965 scopus 로고    scopus 로고
    • Outcome of patients with nasal natural killer (NK)/T-cell lymphoma treated with radiotherapy, with or without chemotherapy
    • Tham IW, Lee KM, Yap SP, et al. Outcome of patients with nasal natural killer (NK)/T-cell lymphoma treated with radiotherapy, with or without chemotherapy. Head Neck 2006; 28: 126-134.
    • (2006) Head Neck , vol.28 , pp. 126-134
    • Tham, I.W.1    Lee, K.M.2    Yap, S.P.3
  • 58
    • 84899737916 scopus 로고    scopus 로고
    • Prognostic factors and curative efficacy of nasal NK/T-cell lymphoma
    • Luo YK, Tan Y, Fu BY, et al. Prognostic factors and curative efficacy of nasal NK/T-cell lymphoma. China Mod Doctor 2010; 48: 26-27.
    • (2010) China Mod Doctor , vol.48 , pp. 26-27
    • Luo, Y.K.1    Tan, Y.2    Fu, B.Y.3
  • 59
    • 84899748685 scopus 로고    scopus 로고
    • Effect of radiotherapy in 20 cases with nasal NK/T-cell lymphoma
    • Chen J, Guo JX, Tao QS, et al. effect of radiotherapy in 20 cases with nasal NK/T-cell lymphoma. J Oncol 2007; 13: 2231-232.
    • (2007) J Oncol , vol.13 , pp. 2231-2232
    • Chen, J.1    Guo, J.X.2    Tao, Q.S.3
  • 60
    • 54049092854 scopus 로고    scopus 로고
    • Clinical features and treatment outcome of nasal-Type NK/T-cell lymphoma of Waldeyer ring
    • Li YX, Fang H, Liu QF, et al. Clinical features and treatment outcome of nasal-Type NK/T-cell lymphoma of Waldeyer ring. Blood 2008; 112: 3057-3064.
    • (2008) Blood , vol.112 , pp. 3057-3064
    • Li, Y.X.1    Fang, H.2    Liu, Q.F.3
  • 61
    • 84861953717 scopus 로고    scopus 로고
    • Complete remission after fi rst-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma
    • Chauchet A, Michallet A S, Berger F, et al. Complete remission after fi rst-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma. J Hematol Oncol 2012; 5: 27.
    • (2012) J Hematol Oncol , vol.5 , pp. 27
    • Chauchet, A.1    Michallet, A.S.2    Berger, F.3
  • 62
    • 84885440628 scopus 로고    scopus 로고
    • Treatment outcome of nasal natural killer/T-cell lymphoma
    • Lee H J, Lee S W, Suh C, et al. Treatment outcome of nasal natural killer/T-cell lymphoma. Radiat Oncol J 2011; 29: 174-180.
    • (2011) Radiat Oncol J , vol.29 , pp. 174-180
    • Lee, H.J.1    Lee, S.W.2    Suh, C.3
  • 63
    • 85008321656 scopus 로고    scopus 로고
    • An analysis of treatment outcome and prognosis on early stage natural killer/T cell lymphoma, nasal type
    • Zheng NY, Shao XF, Mo ZW, et al. An analysis of treatment outcome and prognosis on early stage natural killer/T cell lymphoma, nasal type. China Med Pharm 2012; 2: 40-41.
    • (2012) China Med Pharm , vol.2 , pp. 40-41
    • Zheng, N.Y.1    Shao, X.F.2    Mo, Z.W.3
  • 64
    • 84899734984 scopus 로고    scopus 로고
    • An analysis of pathologic diagnosis and clinical therapy on 55 patients with natural killer/T cell lymphoma
    • Zhao YL, Li QM, Tan XB, et al. An analysis of pathologic diagnosis and clinical therapy on 55 patients with natural killer/T cell lymphoma. China Med Pharm 2011; 18: 5-7.
    • (2011) China Med Pharm , vol.18 , pp. 5-7
    • Zhao, Y.L.1    Li, Q.M.2    Tan, X.B.3
  • 65
    • 84899723894 scopus 로고    scopus 로고
    • The preliminary effecacy of 3D conformal radiotherapy combined with chemotherapy for early stage NK/T-cell lymphoma
    • Dai J, Yang SL, Zhu JH, et al. The preliminary effecacy of 3D conformal radiotherapy combined with chemotherapy for early stage NK/T-cell lymphoma. World Health Dig Med Period 2012; 9: 172-173.
    • (2012) World Health Dig Med Period , vol.9 , pp. 172-173
    • Dai, J.1    Yang, S.L.2    Zhu, J.H.3
  • 66
    • 0345017782 scopus 로고    scopus 로고
    • Therapeutic outcome of extranodal NK/T-cell lymphoma initially treated with chemotherapy-result of chemotherapy in NK/T-cell lymphoma
    • Kim BS, Kim TY, Kim CW, et al. Therapeutic outcome of extranodal NK/T-cell lymphoma initially treated with chemotherapy-result of chemotherapy in NK/T-cell lymphoma. Acta Oncol 2003; 42: 779-783.
    • (2003) Acta Oncol , vol.42 , pp. 779-783
    • Kim, B.S.1    Kim, T.Y.2    Kim, C.W.3
  • 67
    • 3242881605 scopus 로고    scopus 로고
    • Lack of correlation between P-glycoprotein and chemotherapy resistance in nasal NK/T-cell lymphomas
    • Kim GE, Yang WI, Lee SW, et al. Lack of correlation between P-glycoprotein and chemotherapy resistance in nasal NK/T-cell lymphomas. Leuk Lymphoma 2004; 45: 1857-1864.
    • (2004) Leuk Lymphoma , vol.45 , pp. 1857-1864
    • Kim, G.E.1    Yang, W.I.2    Lee, S.W.3
  • 68
    • 0034956452 scopus 로고    scopus 로고
    • Epstein-Barr virus infection, drug resistance and prognosis in Korean T-And NK-cell lymphomas
    • Jung CK, Lee KY, Kim Y, et al. Epstein-Barr virus infection, drug resistance and prognosis in Korean T-And NK-cell lymphomas. Pathol Int 2001; 51: 355-363.
    • (2001) Pathol Int , vol.51 , pp. 355-363
    • Jung, C.K.1    Lee, K.Y.2    Kim, Y.3
  • 69
    • 53549130011 scopus 로고    scopus 로고
    • Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type
    • Wang B, Li XQ, Ma X, et al. Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type. Am J Hematol 2008; 83: 795-799.
    • (2008) Am J Hematol , vol.83 , pp. 795-799
    • Wang, B.1    Li, X.Q.2    Ma, X.3
  • 70
    • 61649109806 scopus 로고    scopus 로고
    • Expression of the multidrug resistance protein MRP and the lung-resistance protein LRP in nasal NK/T cell lymphoma: Further exploring the role of P53 and WT1 gene
    • Huang WT, Huang CC, Weng SW, et al. Expression of the multidrug resistance protein MRP and the lung-resistance protein LRP in nasal NK/T cell lymphoma: Further exploring the role of P53 and WT1 gene. Pathology 2009; 41: 127-132.
    • (2009) Pathology , vol.41 , pp. 127-132
    • Huang, W.T.1    Huang, C.C.2    Weng, S.W.3
  • 71
    • 56549093825 scopus 로고    scopus 로고
    • Autologous hematopoietic stem cell transplantation in extranodal natural killer/T cell lymphoma: A multinational, multicenter, matched controlled study
    • Lee J, Au WY, Park MJ, et al. Autologous hematopoietic stem cell transplantation in extranodal natural killer/T cell lymphoma: A multinational, multicenter, matched controlled study. Biol Blood Marrow Transplant 2008; 14: 1356-1364.
    • (2008) Biol Blood Marrow Transplant , vol.14 , pp. 1356-1364
    • Lee, J.1    Au, W.Y.2    Park, M.J.3
  • 72
    • 81755172136 scopus 로고    scopus 로고
    • Phase ii study of smile chemotherapy for newly diagnosed stage iv, relapsed, or refractory extranodal natural killer (nk)/t-cell lymphoma, nasal type: The nk-cell tumor study group study
    • Yamaguchi M, Kwong YL, Kim WS, et al. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: The NK-Cell Tumor Study Group study. J Clin Oncol 2011; 29: 4410-4416.
    • (2011) J Clin Oncol , vol.29 , pp. 4410-4416
    • Yamaguchi, M.1    Kwong, Y.L.2    Kim, W.S.3
  • 73
    • 84868193440 scopus 로고    scopus 로고
    • Bortezomib in combination with CHOP as fi rst-line treatment for patients with stage III/IV peripheral T-cell lymphomas: A multicentre, single-Arm, phase 2 trial
    • Kim SJ, Yoon DH, Kang HJ, et al. Bortezomib in combination with CHOP as fi rst-line treatment for patients with stage III/IV peripheral T-cell lymphomas: A multicentre, single-Arm, phase 2 trial. Eur J Cancer 2012; 48: 3223-3231.
    • (2012) Eur J Cancer , vol.48 , pp. 3223-3231
    • Kim, S.J.1    Yoon, D.H.2    Kang, H.J.3
  • 74
    • 78751581966 scopus 로고    scopus 로고
    • Treatment of advanced extranodal NK/T cell lymphoma, nasal-Type and aggressive NK-cell leukemia
    • Suzuki R. Treatment of advanced extranodal NK/T cell lymphoma, nasal-Type and aggressive NK-cell leukemia. Int J Hematol 2010; 92: 697-701.
    • (2010) Int J Hematol , vol.92 , pp. 697-701
    • Suzuki, R.1
  • 75
    • 56749102974 scopus 로고    scopus 로고
    • Phase I study of proteasome inhibitor bortezomib plus CHOP in patients with advanced, aggressive T-cell or NK/T-cell lymphoma
    • Lee J, Suh C, Kang HJ, et al. Phase I study of proteasome inhibitor bortezomib plus CHOP in patients with advanced, aggressive T-cell or NK/T-cell lymphoma. Ann Oncol 2008; 19: 2079-2083.
    • (2008) Ann Oncol , vol.19 , pp. 2079-2083
    • Lee, J.1    Suh, C.2    Kang, H.J.3
  • 76
    • 27244449294 scopus 로고    scopus 로고
    • Selective apoptosis of natural killer-cell tumours by l-Asparaginase
    • Ando M, Sugimoto K, Kitoh T, et al. Selective apoptosis of natural killer-cell tumours by l-Asparaginase. Br J Haematol 2005; 130: 860-868.
    • (2005) Br J Haematol , vol.130 , pp. 860-868
    • Ando, M.1    Sugimoto, K.2    Kitoh, T.3
  • 77
    • 79951483189 scopus 로고    scopus 로고
    • Efficacy of L-Asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, aphase 2 study
    • Jaccard A, Gachard N, Marin B, et al. Efficacy of L-Asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, aphase 2 study. Blood 2011; 117: 1834-1839.
    • (2011) Blood , vol.117 , pp. 1834-1839
    • Jaccard, A.1    Gachard, N.2    Marin, B.3
  • 78
    • 67349174996 scopus 로고    scopus 로고
    • L-Asparaginase in the treatment of refractory and relapsed extranodal NK/T-cell lymphoma, nasal type
    • Yong W, Zheng W, Zhu J, et al. L-Asparaginase in the treatment of refractory and relapsed extranodal NK/T-cell lymphoma, nasal type. Ann Hematol 2009; 88: 647-652.
    • (2009) Ann Hematol , vol.88 , pp. 647-652
    • Yong, W.1    Zheng, W.2    Zhu, J.3
  • 79
    • 84899749780 scopus 로고    scopus 로고
    • Prognositc factors and curative efficacy in 84 cases with NK/T-cell lymphoma, nasal type
    • Hu QY, Liu P. Prognositc factors and curative efficacy in 84 cases with NK/T-cell lymphoma, nasal type. J Pract Oncol 2007; 22: 317-321.
    • (2007) J Pract Oncol , vol.22 , pp. 317-321
    • Hu, Q.Y.1    Liu, P.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.